Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00444496 · ClinicalTrials.gov registry record

SPHERE Hypertension Baseline Data Study

A clinical trial of Hypertension, sponsored by University of Washington.

Completed
Registry status
470
Enrollment target
1
Study location

NCT00444496: Completed study of Hypertension, sponsored by University of Washington.

NCT00444496 is a study of Hypertension that has completed, run by University of Washington. The registered enrollment target is 470 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00444496, a study of Hypertension, has completed, sponsored by University of Washington.

COMPLETED
Registry status
470 participants
Enrollment target
1
Study location

Study Summary

We are collecting baseline data on patients who have high blood pressure readings (160/100 or higher) at a 9-1-1 response by an EMT.

Conditions Studied

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 470 participants
Start Date 2007-02
Est. Completion 2007-07
University of Washington

1,048 total trials

What the finished NCT00444496 record still lists

NCT00444496 is an observational study that tracks outcomes without assigning an intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00444496 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00444496 about?

NCT00444496 is a clinical study titled "SPHERE Hypertension Baseline Data Study". We are collecting baseline data on patients who have high blood pressure readings (160/100 or higher) at a 9-1-1 response by an EMT.

What is the current status of trial NCT00444496?

This trial is currently completed. The enrollment target is 470 participants. The study started on 2007-02. Estimated completion is 2007-07.

What conditions does trial NCT00444496 study?

This clinical trial studies the following conditions: Hypertension.

Who is sponsoring clinical trial NCT00444496?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00444496 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00444496's enrollment target sits among peer trials

470 132nd of 470 higher than 339 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05256940 · 470 participants · NA

    Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide

  • NCT05458219 · 470 participants · Phase 1

    A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

  • NCT05850689 · 470 participants · Phase 3

    Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • NCT05935384 · 470 participants

    SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00444496, the US trial registry maintained by the National Library of Medicine. NCT00444496 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.